Percutaneous Approach to Transitional Cell Carcinoma of the Upper Urinary Tract

[1]  A. Zietman,et al.  Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. , 2004, The Journal of urology.

[2]  J. Huguet,et al.  Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. , 2004, The Journal of urology.

[3]  G. MacLennan,et al.  Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. , 2003, Journal of Urology.

[4]  M. Goel,et al.  Percutaneous management of renal pelvic urothelial tumors: long-term followup. , 2003, The Journal of urology.

[5]  U. Studer,et al.  Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. , 2002, The Journal of urology.

[6]  T. Uchida,et al.  Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. , 2002, Urology.

[7]  N. Terada,et al.  Intrarenal bacillus Calmette‐Guérin therapy for carcinoma in situ of the upper urinary tract: long‐term follow‐up and natural course in cases of failure , 2001, BJU international.

[8]  R. Kapoor,et al.  Transitional-cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. , 2001, Journal of endourology.

[9]  A. Patel,et al.  The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma , 2001, BJU international.

[10]  M. Blute,et al.  Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. , 1999, Urology.

[11]  G. Chen,et al.  Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. , 2000, The Journal of urology.

[12]  N. Nonomura,et al.  Bacillus Calmette–Guérin Perfusion Therapy for the Treatment of Transitional Cell Carcinoma in situ of the Upper Urinary Tract , 2000, European Urology.

[13]  Arthur D. Smith,et al.  Primary percutaneous approach to upper urinary tract transitional cell carcinoma. , 2000, The Urologic clinics of North America.

[14]  T. Deguchi,et al.  Bacillus Calmette–Guérin instillation treatment for carcinoma in situ of the upper urinary tract , 2000, BJU international.

[15]  P. Teillac,et al.  Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. , 2000, The Journal of urology.

[16]  S. Rüsch-Gerdes,et al.  Sensitivity of BCG to Modern Antibiotics , 1999, European Urology.

[17]  F. Marshall,et al.  13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes. , 1999, Journal of endourology.

[18]  M. Geisinger,et al.  13-year experience with percutaneous management of upper tract transitional cell carcinoma. , 1999, The Journal of urology.

[19]  G. Fuchs,et al.  New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. , 1998, The Journal of urology.

[20]  M. Bibbo,et al.  Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. , 1997, The Journal of urology.

[21]  N. Bodsworth,et al.  Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. , 1997, Genitourinary medicine.

[22]  M. Bibbo,et al.  Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. , 1997, The Journal of urology.

[23]  L. Martínez-Piñeiro,et al.  Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. , 1996, The Journal of urology.

[24]  M. Igawa,et al.  Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. , 1996, British journal of urology.

[25]  D. Dearnaley,et al.  Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. , 1996, The Journal of urology.

[26]  G. H. Weiss,et al.  Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. , 1995, The Journal of urology.

[27]  K. Delaere,et al.  Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. , 1995, British journal of urology.

[28]  R. Low,et al.  Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. , 1995, The Journal of urology.

[29]  C. Powell,et al.  Track infiltration following percutaneous resection of renal pelvic transitional cell carcinoma. , 1994, British journal of urology.

[30]  G. Bellman,et al.  Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. , 1994, The Journal of urology.

[31]  J. R. Sharpe,et al.  Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. , 1993, The Journal of urology.

[32]  R. Clayman,et al.  Laparoscopic nephroureterectomy: initial clinical case report. , 1991, Journal of laparoendoscopic surgery.

[33]  A. Wein,et al.  The management of transitional cell carcinoma in solitary renal units. , 1991, The Journal of urology.

[34]  K. Wishnow,et al.  Long-term serum creatinine values after radical nephrectomy. , 1990, Urology.

[35]  U. Studer,et al.  Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. , 1989, The Journal of urology.

[36]  J. Huffman,et al.  Endoscopic Diagnosis and Treatment of Upper Tract Urothelial Tumors , 1987 .

[37]  E. Orihuela,et al.  Percutaneous management of renal pelvic tumors: a treatment option in selected cases. , 1987, The Journal of urology.

[38]  E. Pontes,et al.  Percutaneous management of upper tract transitional cell carcinoma. , 1986, The Journal of urology.

[39]  H. Herr.  Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. , 1985, The Journal of urology.

[40]  W. Whitmore,et al.  Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report , 1985, Cancer.

[41]  J. Young,et al.  Bilateral primary carcinoma of the ureter: topical intraureteral thiotepa. , 1984, The Journal of urology.

[42]  H. W. Ferris,et al.  Papillomatous Tumor of the Renal Pelvis Associated with Similar Tumors of the Ureter and Bladder. Review of Literature and Report of Two Cases1 , 1934 .